Skip to content

Inter-Mountain Project on Antimicrobial Resistance and Therapy (IMPART)

Inter-Mountain Project on Antimicrobial Resistance and Therapy (IMPART)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00235703
Enrollment
13000
Registered
2005-10-10
Start date
2001-10-31
Completion date
2005-09-30
Last updated
2006-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper Respiratory Infections

Brief summary

This is a four-year study, funded by the Center for Disease Control and Prevention, related to antimicrobial resistance in rural communities. The project consists of four components: A) surveillance of antimicrobial resistance, B) promotion of appropriate antimicrobial drug prescribing, C) preliminary assessment of the environmental impact of antimicrobials, and D) the development of new antimicrobial products. Six rural communities in Utah, and six rural communities in Idaho are participating in this study. Component D is being performed by investigators at Harvard University, under the direction of Co-Investigator Roger Inouye.

Interventions

DEVICEAntimicrobial Prescribing Decision Support

Sponsors

University of Utah
Lead SponsorOTHER

Study design

Observational model
DEFINED_POPULATION
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
0 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Suspected upper respiratory infection patients in 12 rural communities in Utah and Idaho

Exclusion criteria

\-

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 12, 2026